Causal relationship between immune cells and acute myeloid leukemia: a two-sample Mendelian randomization study

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• Immune cells play a critical role in the development of acute myeloid leukemia (AML).
• The complex nature of AML presents challenges in identifying immunotherapy targets.
• Research on the immune cell-AML connection is nascent, requiring further investigation.

Purpose of the Study:

• To investigate the causal relationship between immune cell phenotypes and acute myeloid leukemia (AML).
• To identify specific immune cell types that may influence AML development or progression.
• To uncover potential therapeutic targets for AML immunotherapy.

Main Methods:

• A bidirectional two-sample Mendelian randomization (MR) study was employed.
• Utilized pooled immune cell phenotypic data from 3,757 individuals and AML data from the FinnGen project.
• Assessed results' sensitivity, heterogeneity, and pleiotropy using statistical methods like Cochran's Q test, MR-Egger, and MR-Presso.

Main Results:

• Identified 26 distinct immune cell types with a potential causal link to AML.
• Revealed a bidirectional causal relationship between Resting Treg % CD4 Treg, BAFF-R on memory B cells, and AML.
• Statistical analyses confirmed the robustness of the identified associations.

Conclusions:

• Established a causal link between specific immune cell phenotypes and AML pathogenesis.
• Highlighted potential therapeutic strategies for AML by modulating immune cell functions.
• Aimed to develop novel treatments targeting immune evasion mechanisms in leukemia.